(Kaplan-Meier plotter: HR= 0.54; p = 0.00063; Figure 8A and GEPIA: p = 0.0035; Figure 8B), (Kaplan-Meier plotter: HR= 0.47; p = 0.00035; Figure 8C and GEPIA: p = 0.034; Figure 8D), and (Kaplan-Meier plotter: HR= 0.51; p = 0.001; Figure 8E and UALCAN: p = 0.046; Figure 8F) respectively. According to these criteria, there was no significant correlation between OS in patients with high BMX expression and OS in patients with low BMX expression in the remaining cancers (Appendix E and Appendix F). The gene discussed is BMX; the disease is cancer.